The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168712 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Fereshteh Sadat Younesi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, University of Toronto, Toronto, ON M5G 1G6, Canada. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Myofibroblasts, Mechanotransduction, Cellular. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 328 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Canadian Institutes of Health Research, CIHR, Canada Foundation for Innovation (CFI) and the Ontario Research Fund (ORF).
Abstract (Originalsprache)
Mesenchymal stromal cells (MSCs) can be isolated from various tissues of healthy or patient donors to be retransplanted in cell therapies. Because the number of MSCs obtained from biopsies is typically too low for direct clinical application, MSC expansion in cell culture is required. However, ex vivo amplification often reduces the desired MSC regenerative potential and enhances undesired traits, such as activation into fibrogenic myofibroblasts. Transiently activated myofibroblasts restore tissue integrity after organ injury by producing and contracting extracellular matrix into scar tissue. In contrast, persistent myofibroblasts cause excessive scarring—called fibrosis—that destroys organ function. In this review, we focus on the relevance and molecular mechanisms of myofibroblast activation upon contact with stiff cell culture plastic or recipient scar tissue, such as hypertrophic scars of large skin burns. We discuss cell mechanoperception mechanisms such as integrins and stretch-activated channels, mechanotransduction through the contractile actin cytoskeleton, and conversion of mechanical signals into transcriptional programs via mechanosensitive co-transcription factors, such as YAP, TAZ, and MRTF. We further elaborate how prolonged mechanical stress can create persistent myofibroblast memory by direct mechanotransduction to the nucleus that can evoke lasting epigenetic modifications at the DNA level, such as histone methylation and acetylation. We conclude by projecting how cell culture mechanics can be modulated to generate MSCs, which epigenetically protected against myofibroblast activation and transport desired regeneration potential to the recipient tissue environment in clinical therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Dentistry, University of Toronto, Toronto, ON M5G 1G6, Canada.
- Keenan Research Institute for Biomedical Science, St. Michael's Hospital, Toronto, ON M5B 1T8, Canada.
ORCID-Profile: Boris Hinz
Förderung
- the Canadian Institutes of Health Research
- CIHR
- Canada Foundation for Innovation (CFI) and the Ontario Research Fund (ORF)
- Canadian Institutes of Health Research
- John Evans Leadership funds
Zitieren
APA
Younesi, F. S., & Hinz, B. (2024). The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168712
Vancouver
Younesi FS, Hinz B. The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168712
BibTeX
@article{Younesi2024,
author = {Younesi, Fereshteh Sadat and Hinz, Boris},
title = {The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168712}
}
EUVIMED